CO.EXIST NUTRITION CORP. – Trademark Portfolio
Entity Type: 03
CO.EXIST NUTRITION CORP. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include 22DAYS and 22 DAYS NUTRITION. The owner is based in MIAMI, FL.
7350 SW 48TH STREET
MIAMI, FL 33155
Showing of trademarks Trademarks
Trademark Classifications
CO.EXIST NUTRITION CORP.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does CO.EXIST NUTRITION CORP. have?
CO.EXIST NUTRITION CORP. has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 cancelled.
What trademark classes does CO.EXIST NUTRITION CORP. file in?
CO.EXIST NUTRITION CORP. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CO.EXIST NUTRITION CORP.'s most well-known trademarks?
CO.EXIST NUTRITION CORP.'s registered trademark portfolio includes well-known marks such as 22DAYS and 22 DAYS NUTRITION. These are among 2 currently registered trademarks in the portfolio.
What is CO.EXIST NUTRITION CORP.'s trademark registration success rate?
CO.EXIST NUTRITION CORP. has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.